218 related articles for article (PubMed ID: 38413370)
1. Cell cycle heterogeneity and plasticity of colorectal cancer stem cells.
Higa T; Nakayama KI
Cancer Sci; 2024 May; 115(5):1370-1377. PubMed ID: 38413370
[TBL] [Abstract][Full Text] [Related]
2. Colorectal Cancer Stem Cells Acquire Chemoresistance Through the Upregulation of F-Box/WD Repeat-Containing Protein 7 and the Consequent Degradation of c-Myc.
Izumi D; Ishimoto T; Miyake K; Eto T; Arima K; Kiyozumi Y; Uchihara T; Kurashige J; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Goel A; Tan P; Baba H
Stem Cells; 2017 Sep; 35(9):2027-2036. PubMed ID: 28699179
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of Lgr5 and CXCR4 characterizes cancer stem-like cells of colorectal cancer.
Wu W; Cao J; Ji Z; Wang J; Jiang T; Ding H
Oncotarget; 2016 Dec; 7(49):81144-81155. PubMed ID: 27835894
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells.
Kemper K; Prasetyanti PR; De Lau W; Rodermond H; Clevers H; Medema JP
Stem Cells; 2012 Nov; 30(11):2378-86. PubMed ID: 22969042
[TBL] [Abstract][Full Text] [Related]
5. GPR56 Drives Colorectal Tumor Growth and Promotes Drug Resistance through Upregulation of MDR1 Expression via a RhoA-Mediated Mechanism.
Zhang S; Chatterjee T; Godoy C; Wu L; Liu QJ; Carmon KS
Mol Cancer Res; 2019 Nov; 17(11):2196-2207. PubMed ID: 31444231
[TBL] [Abstract][Full Text] [Related]
6. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
Eun K; Ham SW; Kim H
BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
[TBL] [Abstract][Full Text] [Related]
7. Visualization and targeting of LGR5
Shimokawa M; Ohta Y; Nishikori S; Matano M; Takano A; Fujii M; Date S; Sugimoto S; Kanai T; Sato T
Nature; 2017 May; 545(7653):187-192. PubMed ID: 28355176
[TBL] [Abstract][Full Text] [Related]
8. LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution.
Kobayashi S; Yamada-Okabe H; Suzuki M; Natori O; Kato A; Matsubara K; Jau Chen Y; Yamazaki M; Funahashi S; Yoshida K; Hashimoto E; Watanabe Y; Mutoh H; Ashihara M; Kato C; Watanabe T; Yoshikubo T; Tamaoki N; Ochiya T; Kuroda M; Levine AJ; Yamazaki T
Stem Cells; 2012 Dec; 30(12):2631-44. PubMed ID: 23081779
[TBL] [Abstract][Full Text] [Related]
9. The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma.
Das PK; Islam F; Lam AK
Cells; 2020 Jun; 9(6):. PubMed ID: 32503256
[TBL] [Abstract][Full Text] [Related]
10. Clusterin: a marker and mediator of chemoresistance in colorectal cancer.
Hlavca S; Chan WH; Engel RM; Abud HE
Cancer Metastasis Rev; 2024 Mar; 43(1):379-391. PubMed ID: 38319453
[TBL] [Abstract][Full Text] [Related]
11. Lgr5 promotes cancer stemness and confers chemoresistance through ABCB1 in colorectal cancer.
Liu YS; Hsu HC; Tseng KC; Chen HC; Chen SJ
Biomed Pharmacother; 2013 Oct; 67(8):791-9. PubMed ID: 24138824
[TBL] [Abstract][Full Text] [Related]
12. Clinical Implications of Colorectal Cancer Stem Cells in the Age of Single-Cell Omics and Targeted Therapies.
Frank MH; Wilson BJ; Gold JS; Frank NY
Gastroenterology; 2021 May; 160(6):1947-1960. PubMed ID: 33617889
[TBL] [Abstract][Full Text] [Related]
13. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
[TBL] [Abstract][Full Text] [Related]
14. Deciphering the Role of Intestinal Crypt Cell Populations in Resistance to Chemotherapy.
Frau C; Jamard C; Delpouve G; Guardia GDA; Machon C; Pilati C; Nevé CL; Laurent-Puig P; Guitton J; Galante PAF; Penalva LO; Freund JN; de la Fouchardiere C; Plateroti M
Cancer Res; 2021 May; 81(10):2730-2744. PubMed ID: 33741693
[TBL] [Abstract][Full Text] [Related]
15. Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.
De Angelis ML; Zeuner A; Policicchio E; Russo G; Bruselles A; Signore M; Vitale S; De Luca G; Pilozzi E; Boe A; Stassi G; Ricci-Vitiani L; Amoreo CA; Pagliuca A; Francescangeli F; Tartaglia M; De Maria R; Baiocchi M
Stem Cells Transl Med; 2016 Apr; 5(4):511-23. PubMed ID: 26956206
[TBL] [Abstract][Full Text] [Related]
16. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
17. Spheroid-Formation (Colonosphere) Assay for in Vitro Assessment and Expansion of Stem Cells in Colon Cancer.
Shaheen S; Ahmed M; Lorenzi F; Nateri AS
Stem Cell Rev Rep; 2016 Aug; 12(4):492-9. PubMed ID: 27207017
[TBL] [Abstract][Full Text] [Related]
18. Characterization of cancer stem cells from different grades of human colorectal cancer.
Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
[TBL] [Abstract][Full Text] [Related]
19. A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer?
Mirzaei A; Tavoosidana G; Rad AA; Rezaei F; Tavakoli-Yaraki M; Kadijani AA; Khalili E; Madjd Z
Tumour Biol; 2016 Feb; 37(2):2405-14. PubMed ID: 26383518
[TBL] [Abstract][Full Text] [Related]
20. Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer.
Fumagalli A; Oost KC; Kester L; Morgner J; Bornes L; Bruens L; Spaargaren L; Azkanaz M; Schelfhorst T; Beerling E; Heinz MC; Postrach D; Seinstra D; Sieuwerts AM; Martens JWM; van der Elst S; van Baalen M; Bhowmick D; Vrisekoop N; Ellenbroek SIJ; Suijkerbuijk SJE; Snippert HJ; van Rheenen J
Cell Stem Cell; 2020 Apr; 26(4):569-578.e7. PubMed ID: 32169167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
